Search results
Daniel Lucius Vasella (born 15 August 1953) is a Swiss medical doctor, author, and executive who was CEO and chairman of the Swiss pharmaceutical company Novartis AG, the world's fifth largest drug company.
Sep 1, 2012 · Daniel Vasella, former CEO of Novartis, shares his insights on leading in the 21st century. He discusses the challenges and opportunities of the health care industry, the role of innovation, compliance, and resilience.
Daniel Vasella, Swiss doctor and businessman who served as chairman (1999–2013) and CEO (1996–2010) of the pharmaceutical company Novartis. Learn more about Vasella’s life and career, including information about his tenure at Novartis as well as his other board memberships.
Mar 1, 2007 · As high-risk career moves go, this one played out brilliantly. Within a decade, Dr. Daniel Vasella (PMD 57, 1989) rocketed through the ranks of Sandoz and in 1996 led the firm’s merger with Ciba-Geigy, emerging as CEO of the new company called Novartis, based in Basel, Switzerland.
Feb 21, 2013 · Wonder manager or symbol of the fat cat culture? Switzerland could hardly have witnessed a more polarising corporate figure in the past 20 years than outgoing Novartis boss Daniel Vasella.
Jul 1, 2009 · Dan Vasella, CEO and chairman of Novartis AG, leads off our video interview series McKinsey conversations with global leaders. This ongoing project explores vital management issues, industry insights, and topical analysis with CEOs of today’s leading global companies.
Aug 25, 2013 · For a man with outspoken views, Daniel Vasella has been curiously quiet during the past six months, since he announced his plans to step down from the chairmanship of Novartis amid a furore about...
